Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Dose Escalation Study of Stereotactic BOOST for Prostate cancER

NCT02004223 is registered in ClinicalTrials.gov with Royal North Shore Hospital as lead sponsor.

NCT NCT02004223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02004223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Dose Escalation Study of Stereotactic BOOST for Prostate cancER
Lead sponsor
Royal North Shore Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2014
Completion date
December 31, 2018
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer